Botulism Prevention

  • STATUS
    Recruiting
  • sponsor
    Ology Bioservices
Updated on 12 December 2022

Summary

A Phase 2, multicenter, randomized, double-blinded, placebo-controlled study to evaluate repeat dose (50 mg and 100 mg) of G03-52-01 administered by IM injection(s) in adult subjects. Approximately 375 subjects will be enrolled in this study.

Description

A Phase 2, randomized, double-blind, placebo-controlled repeat dose trial

Details
Condition Vaccines
Clinical Study IdentifierTX304030
SponsorOlogy Bioservices
Last Modified on12 December 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Healthy adult 18 to 65 years of age
Able and willing to comply and be available for all protocol procedures and follow-up for the duration of the study

Exclusion Criteria

History of any uncontrolled or chronic medical conditions that would either interfere with the accurate assessment of the objectives of the study or increase the risk profile of the subject based on Investigator judgement
Known history of severe allergic reaction of any type to medications, bee stings, food, or environmental factors or hypersensitivity or reaction to immunoglobulins
Known allergic reactions to any of the study product components present in the formulation or in the processing
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note